Skyrizi Launch Skyrockets, Boosting AbbVie Hopes For Humira Successors

 
• By Joseph Haas
Pebble tower on the seaside - Image
AbbVie is successfully balancing Humira's biosimilar erosion with new brand growth

More from Earnings

More from Business